Skip to content

Comparison of Agitation in recovery after mastectomy in patients receiving dexamethasone in comparison with placebo in Imam Khomeini Hospital Operating room, 1391-1392

Comparison of Agitation in recovery after mastectomy in patients receiving dexamethasone in comparison with placebo in Imam Khomeini Hospital Operating room, 1391-1392

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201306139213N2
Enrollment
104
Registered
2014-01-08
Start date
2012-09-19
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

agitation. Restlessness and agitation

Interventions

Intervention 1: Group 1 placebo: 2 milliliters sterile water, IV during 30 seconds. Intervention 2: Group 2, dexamethasone group: 8 milligrams dexamethasone, IV, post-induction and pre-intubation, dur
Prevention
Group 1 placebo: 2 milliliters sterile water, IV during 30 seconds
Group 2, dexamethasone group: 8 milligrams dexamethasone, IV, post-induction and pre-intubation, during 30 seconds

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1. aged between 18 and 65 years 2. mastectomy surgery Exclusion criteria: 1. antiemetic consumption after surgery 2. a positive history of psychiatric or CNS disorders 3. having diabetics or uncontrolled blood pressure 4. analgesic consumption before surgery 5. a history of substance abuse consuming or other medications

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Agitation. Timepoint: 10 minutes after transfer to recovery room. Method of measurement: By applying the standard RASS questionnaire (attached) post-anesthesia agitation is assessed 10 minutes after transfer to recovery room. This questionnaire consists of 10 levels (from +4 to -5) in which values more than +1 are considered emergent delirium or agitation per se.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Jalil Makarem

Tehran University of Medical Sciences

makaremj@yahoo.com+98 21 6658 1576

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026